Taken together, the data show that PAH patients have higher leptin levels in circulation than controls, despite having a similar BMI to controls, and that plasma leptin abundance correlates with higher BMI and is reduced by metformin treatment. Here, LEP is linked to pulmonary arterial hypertension.